Hofseth Biocare ASA (0Q6H) Stock Statistics & Valuation Metrics
Total Valuation
Hofseth Biocare ASA has a market cap or net worth of NOK 618.85M. The enterprise value is NOK 797.22M.
- Market Cap
- NOK 618.85M
- Enterprise Value
- NOK 797.22M
Share Statistics
Hofseth Biocare ASA has 506,235,630 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 506,235,630
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Hofseth Biocare ASA’s return on equity (ROE) is -1.99 and return on invested capital (ROIC) is -49.09%.
- Return on Equity (ROE)
- -1.99
- Return on Assets (ROA)
- -0.36
- Return on Invested Capital (ROIC)
- -49.09%
- Return on Capital Employed (ROCE)
- -0.66
- Revenue Per Employee
- 3.18M
- Profits Per Employee
- -1.52M
- Employee Count
- 81
- Asset Turnover
- 0.75
- Inventory Turnover
- 3.03
Valuation Ratios
The current PE Ratio of Hofseth Biocare ASA is -5.58. Hofseth Biocare ASA’s PEG ratio is 1.67.
- PE Ratio
- -5.58
- PS Ratio
- 2.49
- PB Ratio
- 26.41
- Price to FCF
- -16.09
- Price to Operating Cash Flow
- -18.93
- PEG Ratio
- 1.67
Income Statement
In the last 12 months, Hofseth Biocare ASA had revenue of 257.42M and earned -123.41M in profits. Earnings per share was -0.30.
- Revenue
- 257.42M
- Gross Profit
- 87.86M
- Operating Income
- -113.98M
- Pretax Income
- -123.41M
- Net Income
- -123.41M
- EBITDA
- -69.83M
- Earnings Per Share (EPS)
- -0.30
Cash Flow
In the last 12 months, operating cash flow was -37.58M and capital expenditures -4.29M, giving a free cash flow of -42.48M billion.
- Operating Cash Flow
- -37.58M
- Free Cash Flow
- -42.48M
- Free Cash Flow per Share
- -0.10
Dividends & Yields
Hofseth Biocare ASA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -6.21%
- Earnings Yield
- -17.93%
Stock Price Statistics
- Beta
- 0.57
- 52-Week Price Change
- -26.91%
- 50-Day Moving Average
- 1.38
- 200-Day Moving Average
- 1.37
- Relative Strength Index (RSI)
- 1.09
- Average Volume (3m)
- 11.00K
Important Dates
Hofseth Biocare ASA upcoming earnings date is Nov 06, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 21, 2026
- Next Earnings Date
- Nov 06, 2026
- Ex-Dividend Date
- ―
Financial Position
Hofseth Biocare ASA as a current ratio of 0.67, with Debt / Equity ratio of 275.64%
- Current Ratio
- 0.67
- Quick Ratio
- 0.33
- Debt to Market Cap
- 0.10
- Net Debt to EBITDA
- -2.08
- Interest Coverage Ratio
- -7.27
Taxes
In the past 12 months, Hofseth Biocare ASA has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Hofseth Biocare ASA EV to EBITDA ratio is -11.83, with an EV/FCF ratio of -19.96.
- EV to Sales
- 3.09
- EV to EBITDA
- -11.83
- EV to Free Cash Flow
- -19.96
- EV to Operating Cash Flow
- -22.56
Balance Sheet
Hofseth Biocare ASA has NOK 71.95M in cash and marketable securities with NOK 236.19M in debt, giving a net cash position of -NOK 164.24M billion.
- Cash & Marketable Securities
- NOK 71.95M
- Total Debt
- NOK 236.19M
- Net Cash
- -NOK 164.24M
- Net Cash Per Share
- -NOK 0.32
- Tangible Book Value Per Share
- -NOK 0.04
Margins
Gross margin is 31.46%, with operating margin of -39.50%, and net profit margin of -46.52%.
- Gross Margin
- 31.46%
- Operating Margin
- -39.50%
- Pretax Margin
- -46.52%
- Net Profit Margin
- -46.52%
- EBITDA Margin
- -26.13%
- EBIT Margin
- -40.49%
Analyst Forecast
The average price target for Hofseth Biocare ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- -8.89%
- EPS Growth Forecast
- -1.06%
